Our Services
- R&D Portfolio Management
- Asset Valuation
- Strategy Development
- Organisational Effectiveness
- Innovation Management
- Marketing Excellence
- Personalised Medicine
- Executive Education Services
Learn more about how Catenion can help you with your business.
Spotlight
Biotechisation of pharma
The biotechisation of pharma companies and other current experimental approaches of Big Pharma to increase R&D productivity and innovativeness will have major influences on the nature of pharma-biotech collaborations.
Download this article…
Executive Briefing on Post Merger Integration — Capturing Deal Value through Strategic Vision and Rigorous Process
There are many valid reasons why companies pursue mergers & acquisitions (M&A) as part of their strategic growth plans. These include portfolio diversification, addition of top–line growth, acquisition of key technology, geographical expansion, or some combination of the above. However, the acquiring company is typically required to pay a premium of up to 30% in order to win the deal competition, and to satisfy shareholders of the target company.
Download this executive briefing…
Catenion is a management consulting firm devoted to helping pharmaceutical and medical products companies significantly increase the returns on their R&D and marketing investments by creating more innovative and effective strategies and organisations. Read more...
"I tremendously enjoyed working with Catenion. They are fully at home in pharmaceutical Discovery and bring a highly unusual combination of a rigorous analytical mind–set with a pragmatic understanding of R&D strategy and organisational mechanics."
Dr. Gianni Gromo
Global Head Metabolic &
Vascular Disease Area
F. Hoffmann–La Roche AG
2012 Catenion GmbH. Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 Germany. 